“Bausch Health is actively donating medicines and health care products to assist in the global fight against COVID-19 while also pursuing research to determine if products in our existing portfolio may offer valuable treatment options,” said Joseph C. Papa, chairman and CEO, Bausch Health. “In line with our mission of improving people’s lives with our health care products, we will continue to seek opportunities to offer support and aid to the institutions, patients and health care providers battling this pandemic.”
- In Europe, the Company is ramping up the manufacturing of chloroquine and azithromycin and is seeking emergency access in certain countries with the goal of donating these products where and when needed.
- In Italy, the Bausch Foundation is making available for donation its antiviral VIRAZOLE® (Ribavirin for Inhalation Solution, USP) for nebulization in compassionate use in Italian hospitals.
- In Spain, the Bausch Foundation is making available for donation ARTELAC® Splash™ eye drops for use in local hospitals.
- In the United States, the Company’s gastroenterology business Salix Pharmaceuticals is working with key opinion leaders to initiate investigative trials to evaluate XIFAXAN® (rifaximin) in combination with established therapies, supportive care and other investigative therapies to potentially address the symptoms of gastrointestinal distress and pulmonary compromise associated with COVID-19 infection. If the trials demonstrate XIFAXAN is successful in resolving these symptoms or reducing the duration of COVID-19, the Bausch Foundation will donate XIFAXAN to various hospitals.
- In Wuhan, China, health care providers treating patients with COVID-19 reported that they were hindered by fogging eyeglasses while wearing protective gear, such as goggles, face masks and containment suits. The Company’s global eye health business Bausch + Lomb responded by donating Biotrue® ONEday daily disposable contact lenses to these health care providers.
- At its Jinan, China production facility, Bausch + Lomb is converting an available production line to produce hand sanitizer that will be donated for health care providers, first responders and volunteers.
- The Bausch Health Patient Assistance Program (PAP) continues to ensure that eligible U.S. patients in need who lack health insurance coverage for certain Bausch Health medicines are able to access their prescription medicines. During this time when many health care offices are not operating on regular schedules, the PAP has increased its efforts to work with patients and physicians’ offices to ensure patients have uninterrupted access to their medicines.